FDA Approved: POSLUMA — Supplemental Application (Blue Earth Diagnostics)

View source ↗

Summary

The FDA approved a supplemental application for POSLUMA (flotufolastat F-18) from Blue Earth Diagnostics, expanding its labeling for PET imaging in prostate can…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Cancer

Drugs mentioned

• POSLUMA (FLOTUFOLASTAT F-18)

Snippet

SUPPL AP for POSLUMA (FLOTUFOLASTAT F-18)